JPRN-UMIN000012114已完成未知
Phase II study of nab-paclitaxel in patients with previously treated non-small cell lung cancer - Phase II study of nab-paclitaxel in patients with previously treated non-small cell lung cancer
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 入组人数
- 30
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1)Small cell carcinoma (in the whole or a part of the tumor) 2)Interstitial pneumonia or pulmonary fibrosis detectable on X ray 3)Uncontrolled pleural effusion, ascites, or pericardial effusion 4)Symptomatic brain metastasis 5)Active synchronous malignant neoplasm 6)Uncontrolled diabetes or hypertension 7)History of severe heart disease 8)Anamnesis of hypersensitivity to paclitaxel or albumin 9)Anamnesis of hypersensitivity to drugs 10)Patients with severe infection 11)Pregnancy or lactating patients 12)Patients who were judged inappropriate to entry this study by physician
研究者
相似试验
已完成
2 期
Phase 2 study of Nab-Paclitaxel for patients with previously treated EGFR wild-type non-small-cell lung cancer.on-small-cell lung cancerJPRN-UMIN000018233Shimane university hospital45
已完成
不适用
Phase II Study of nab-paclitaxel in Treated Patients with Advanced Non-Small Cell Lung CancerTreated patients with advanced non-small cell lung cancerJPRN-UMIN000015841Tohoku Medical and Pharmaceutical University30
招募中
不适用
Phase2 study of Nab-Paclitaxel in patients with unresectable or advanced squamous cell lung cancersquamous cell lung cancerJPRN-UMIN000014558Tottori University Faculty of Medicine27
招募中
2 期
Phase II study of nab-paclitaxel in combination with carboplatin in patients with refractory small-cell lung cancerRefractory small-cell lung cancerJPRN-UMIN000015565Dokkyo Medical University22
已完成
2 期
Phase II pilot study of nab-paclitaxel in patients with metastatic or unresectable urothelial cancer previously treated with cisplatin-based chemotherapy.urothelial cancerJPRN-UMIN000015260Department of Urology, Saitama Medical Center, Saitama Medical University5